Designed for minimally invasive procedures, the AtriClip PRO-Mini® device is a low-profile option, offering surgeons optimized visualization for permanent LAA Exclusion.

Learn more about AtriClip PRO-Mini here: <a href="https://t.co/BIhve7q6lm&quot; target="_blank">https://t.co/BIhve7q6lm</a&gt;

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a>

We’re thrilled to host the inaugural Cryo Nerve Block Summit on April 23–24, bringing together leading experts and clinicians in cardiac and thoracic care.
Expect insights on:

 - Advances in Cryo Nerve Block Therapy
- Real‑world approaches to modern pain management
- The latest clinical evidence and best practices

The summit is a great chance to connect, exchange experiences, and learn from peers who are shaping the future of post-operative pain management.

Register and join us in Barcelona: <a href="https://lnkd.in/ebnERFMp&quot; target="_blank">https://lnkd.in/ebnERFMp</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=painmanagement&highligh…; target='_blank'>#painmanagement</a> 

We’re grateful for the doctors whose skill, dedication, and care transform patient lives every day. Thank you for all you do. <a href="https://twitter.com/hashtag/DoctorsDay?src=hashtag_click&quot; target="_blank">#DoctorsDay</a>

Just two weeks to go until <a href='https://www.linkedin.com/feed/hashtag/?keywords=EHRA2026&highlightedUpd…; target='_blank'>#EHRA2026</a> in Paris! Here you’ll have the opportunity to join best-in-class educational programs on how Hybrid AF™ Therapies can address unmet clinical needs in complex AF treatment at our booth E900, as well as gain hands-on experience in the EHRA Simulation Village.

Learn more: <a href="https://bit.ly/47B6zBG&quot; target="_blank">https://bit.ly/47B6zBG</a&gt;

European Society of Cardiology

<a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=EHRA&highlightedUpdateU…; target='_blank'>#EHRA</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cardiology&highlightedU…; target='_blank'>#cardiology</a>

We caught up with Dr. Richard Whitlock to discuss the BoxX-NoAF trial, studying if surgical ablation + LAAE during cardiac surgery can prevent new-onset post-op Afib in at-risk patients with no prior history.

Learn more: <a href="https://t.co/WrDP1tNO23&quot; target="_blank">https://t.co/WrDP1tNO23</a&gt;

<a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> <a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click&quot; target="_blank">#ClinicalTrial</a>

AtriClip represents two decades of continuous innovation in left atrial appendage exclusion solutions.

Discover why it’s the global choice: <a href="https://t.co/xxzH5phMpp&quot; target="_blank">https://t.co/xxzH5phMpp</a&gt;

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Headed to <a href="https://twitter.com/hashtag/AATS2026?src=hashtag_click&quot; target="_blank">#AATS2026</a>? Stop by the AtriCure booth to get hands-on with the global leader in LAAE, the AtriClip device, and explore the Isolator® Synergy™ EnCompass® Clamp for surgical ablation. See you there!

Experience you can trust. Innovation that lasts.

The EnCompass clamp has been used in 30,000+ patients and is backed by 20+ years of surgical ablation innovation — refined to support consistent performance and reliable lesion formation in the OR.

Learn more:

AF and Heart Failure.​
​
Two conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.​
​
Both affect millions of people and after age 40:​
​
1 in 4 people will develop AF​
1 in 5 people will develop HF​
​
And, regardless of which comes first - patients with AF and HF together have significantly worse prognosis. ​
​
Learn more about the impact of heart failure and AF: <a href="https://okt.to/ALk5Hv&quot; target="_blank">https://okt.to/ALk5Hv</a&gt; ​
​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=HeartFailure&highlighte…; target='_blank'>#HeartFailure</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>​

At <a href="https://twitter.com/hashtag/HRS2026?src=hashtag_click&quot; target="_blank">#HRS2026</a> we'll be connecting with surgeons as we share a durable treatment option for advanced Afib patients and discuss how to manage the left atrial appendage in minimally invasive cases with our latest innovation, the AtriClip PRO-Mini® device. We hope to see you there!